Sponsor Pipeline

Zhejiang Doer Biologics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07680829 A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia Severe Hypertriglyceridemia Not Yet Recruiting
NCT07693777 A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With… Severe Hypertriglyceridemia (sHTG) Not Yet Recruiting
Phase 2
NCT07024212 Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and… MASLD Active, Not Recruiting
Phase 1/2
NCT07056777 Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard… Gastrointestinal Cancer Recruiting
Phase 1
NCT06132828 Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced… Solid Tumor Recruiting
Get alerts when Zhejiang Doer Biologics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free